MGMT and brain neoplasm: Depletion of MGMT activity by the selective inhibitor, O6-BG, reportedly enhanced the cytotoxicity of TMZ in human brain tumour (Bobola et al, 1996) and melanoma (Wedge et al, 1997) xenografts.